Plenary Speakers

FLUID AND PET IMAGING BIOMARKERS FOR ALZHEIMER’S AND PARKINSON’S DISEASES

Oskar Hansson (Sweden)

STOMPING OUT THE SPARK: TARGETING PYROGLU3 Amyloid-beta FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Cynthia Lemere (USA)

KEY MILESTONES IN ALZHEIMER’S DISEASE

Samantha Budd-Haeberlein (USA)

TAU AND DIVERSITY OF DRIVERS IN ALZHEIMER DISEASE

Bradley Hyman

DISEASE MODIFICATION IN PD: WHAT ARE THE PROMISING TARGETS?

Anthony Lang (Canada)

MICROGLIAL TAM RECEPTORS IN ALZHEIMER’S DISEASE

Greg Lemke (USA)